Kalorama Information is a dependable resource for information on opportunity in the pharmaceutical market. The pharma industry has seen important developments in the last few years, bringing both challenges and new opportunities. The industry outlook for many manufacturers has changed due to outsourcing in drug discovery, growing generic competition and greater interest in biotechnology, among other developments. Our reports provide the sales data, revenue forecasts, and competitive analysis that one needs to understand the market.
Vaccines
Drug Delivery
Over-the-Counter
Drug Discovery
Cancer Treatment
Manufacturing & Packaging
Prescription Drugs

    World Market for Anti-infectives Volume II: The World Market for Antibacterial Medications, The

    Published: January 1, 2003 | Price: $2,500.00 – $5,000.00

    Antibiotic development has never proceeded at this pace or with this much urgency. Demand for effective antibacterial compounds is growing rapidly and companies are trying to fill their pipelines with products that can meet the challenges of increasingly stubborn infectious agents. By far the largest of the anti-infective segments, antibacterials represent approximately 65% of the $20 billion world market in infectious disease drugs. However, it’s also the most crowded of the segments with big pharma and small biotech companies alike...
    Growth Factor Inhibitors: Markets and Opportunities for a Growing Pipeline

    Published: March 1, 2004 | Price: $3,500.00 – $7,000.00

    Growth factors are gene products that play important roles in the regulation of cell division and tissue proliferation. Generally, the binding of a growth factor to its receptor initiates or blocks the ability of cells to divide and multiply. Blood and tissue growth factors have become exciting targets for compounds intended to inhibit or slow the mechanisms involved in their function or growth. This report highlights the research into, and the current and potential key world markets for, products that...
    The U.S Market for Over-the-Counter Cough, Cold, Allergy, and Sinus Medications

    Published: July 1, 2005 | Price: $3,000.00 – $6,000.00

    This report on the U.S. market for over-the-counter (OTC) cough, cold, sinus and allergy (CCSA) medication presents an in-depth analysis of the performance of various CCSA drugs in the U.S. market. The analysis captures the performance of the market players, drug categories, and leading brands in terms of revenues and growth. It also identifies key issues, drivers, challenges, regulations, and trends affecting the marketplace. In addition, the report provides a detailed analysis of consumer demographics and preferences in terms of...
    Diabetes and Diabetic Complications: Major World Markets, 2nd Edition

    Published: April 1, 2005 | Price: $3,500.00 – $7,000.00

    The current market for diabetes products is large and growing. Both monitoring and therapeutic products have an excellent market outlook. Diabetes markets have long had major areas of unmet need, and that has not changed during the past several decades. In fact, the number of diabetic patients, especially in the United States, will increase at an accelerating rate over the next 20 years. With the recognition of diabetes as a public health issue of increasing importance, greater pressure will be...
    Precision Cancer Therapeutics Market, 2022

    Published: October 25, 2022 | Price: $5,000.00 – $10,000.00

    Despite advances in cancer treatment, cancer continues to affect about 18.1 million people annually, generating a significant loss of life, financial burden and overall strain on the health industry.  Worldwide between 35 and 40 million people are living with cancer and nearly 10 million people lose the battle annually.  The most common cancers affecting the world population include lung, breast, colon/rectum, stomach, liver, prostate, cervical, esophageal, and bladder. Cancer deaths occur in about 50% of people who develop cancer in...
    Cell Therapy and Gene Therapy Markets (Markets by Disease Type), 2023-2029

    Published: April 30, 2024 | Price: $5,000.00 – $10,500.00

    Authoritative market research on cell therapy, gene therapy, and RNA therapy analyzing markets by disease type Cell therapy and gene therapy represent a frontier in modern medicine, promising revolutionary treatments by treating the underlying genetic causes of disease and by genetically controlling the body's immune system.  Recent years have seen an increase in new therapies and the pipeline indicates this trend will continue.  A large range of therapeutic areas from oncology to cardiology have seen rapidly proliferating clinical trials. Cell...
    Outsourcing in Drug Development – The Contract Research Market from Preclinical to Phase III

    Published: January 1, 2004 | Price: $3,500.00 – $7,000.00

    The cost of drug development has soared during the past ten years compelling pharmaceutical and biotechnology companies to look for new, smarter ways of conducting clinical research. Driven by mounting market pressures, companies are increasingly implementing outsourcing strategies to increase revenues through faster drug development. By decreasing their in-house facilities and staff, and outsourcing more of their R&D functions, pharmaceutical and biotechnology companies are reshaping the drug development services industry. This industry has evolved from providing limited clinical trial services...
    World Market for Prescription Orthopedic Drugs, The

    Published: October 1, 2006 | Price: $995.00 – $7,000.00

    The orthopedic drug market is a highly competitive market and, in some areas, the competitive environment is being shaped by increasing levels of generic competition. Several large pharmaceutical companies compete in the orthopedic drug market, including Abbott, Eli Lilly, GlaxoSmithKline, Merck, Novartis, and Pfizer among others, and several other suppliers, such as Serono, NovoNordisk, Amgen, and Genentech are developing or offering products in more niche market areas. For the purposes of this study, the world market for orthopedic drugs has...
    Women’s Health: Worldwide Prescription Drug Markets – 3rd Edition

    Published: March 1, 2003 | Price: $2,812.00 – $5,625.00

    During the last 25 years, there have been unprecedented advancements in the area of women’s health and there is widespread recognition of the importance of addressing conditions that overwhelmingly affect women. Likewise, pharmaceutical marketers have increasingly understood the potential that the women’s health market represents and the increasing clout female consumers are wielding in the prescription drug marketplace. Women’s Health: Worldwide Prescription Drug Markets is a comprehensive study of the pharmaceutical markets aimed at diseases and conditions that affect women....
    H1N1 “Swine Flu” Vaccine Market Review (Revenues, Forecasts, Lessons for Future Pandemic Vaccines)

    Published: May 1, 2010 | Price: $500.00 – $2,400.00

    The H1N1 flu epidemic created a public health emergency in 2009. It also created an opportunity for vaccine manufacturers to demonstrate that working with governments of the US and countries around the world, they could manufacture and distribute a vaccine for the virus strain that may have had an impact in reducing cases and deaths. Who were the companies that performed best in this market? How did goverment contracts play out? Most importantly, what are lessons for future pandemic and...
    World Cardiovascular Drug Market, (Antihypertensives, Antihyperlipidemics, Vasodilators, Anticoagulants, Diuretics and other Agents) , The

    Published: December 1, 2007 | Price: $995.00 – $7,990.00

    Kalorama's 2nd edition of The World Cardiovascular Drugs Market, in its 2nd edition, will steer marketers through the sheer size and diversity of the current market and the potential of new products that will make this therapeutic category among the most competitive of prescription drug segments. Analyst Mary Ann Crandall considers both the exisiting products and the pipeline in this comprehensive market study. The following market segments are covered: Cardiac Glycosides and Positive Inotropic Agents Antihypertensive Agents (ACE Inhibitors, Angiotensin...
    Biosimilar Market Trends 2019

    Published: May 8, 2019 | Price: $3,000.00 – $6,000.00

    Biopharmaceuticals are synthetic or recombinant versions of natural biologic substances, including proteins such as enzymes or antibodies, and nucleic acids such as DNA or RNA. Generic products are non-patented chemical and therapeutic equivalents of brand name drugs. However, biosimilars are not generic biologics because there can be no generic form of biologics due to the complex process of creating biologics. Biosimilar Market Trends 2019 is designed to provide a snapshot of issues and trends that are affecting the biosimilar market...
    Pharmaceutical Products of the Future: 50-Company Biopharma and Traditional Pipeline Analysis to 2016

    Published: August 3, 2012 | Price: $2,500.00 – $5,000.00

    What Will the Pharma Industry Look Like in 5 Years? There are an estimated 724 projects in development from the top 50 pharmaceutical companies.  Together, they have the potential to add billions in value to the current pharmaceutical market in the next five years. What types of drugs are companies developing and what will be the impact of these products on the marketplace and key competitors?   In this report, Kalorama Information has analyzed the late-stage R&D pipeline of the...
    Worldwide Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals), The

    Published: October 1, 2009 | Price: $3,500.00 – $7,000.00

    The anti-infective market is at a critical juncture. For the past 60 years, antibiotic drugs have turned bacterial infections into treatable conditions rather than the life-threatening scourges they once were. But the effectiveness of many antibiotics is waning dramatically, as more and more types of bacteria become resistant to them. This Kalorama Information The World Market for Anti-Infectives considers the anti-infective drug market as it faces challenges with resistance and generic competition. The report focuses on three key segments of...
    The World Market for Transdermal Drug Delivery

    Published: September 13, 2012 | Price: $995.00 – $1,990.00

    Transdermal (and related transmucosal)  drug delivery is a well-established accepted route of administration for therapeutically beneficial medicines. There is no potential limit for the therapeutic area for development of transdermal systems. Some therapeutic areas stand out, including sex hormones and pain management, due to the successful combination of the individual drug molecules and available product technologies. The potential benefits that may be achieved using transdermal delivery include continuous, controlled release and absorption of medication into the body, avoiding presystemic metabolism...